ACQUISITION OF CORE ONCOLOGY'S PROSTATE BRACHYTHERAPY CUSTOMER BASE (Tables)

9 Months Ended

Sep. 30, 2012

Asset Acquisition Disclosure [Abstract]

Schedule of finite-lived intangible assets acquired as part of business combination

	Amount		Estimated Life
Inventory	$	258
Developed technology equipment		187	7 years
Intangibles
Customer relationships		4,539	7 years
Non-compete agreements		384	5 years
Developed technology		110	1.5 years
		5,033	6.7 years
Total estimated cost of assets acquired	$	5,478